Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (428)	6/19/2002 12:50:52 PM
From: Jibacoa	Read Replies (1) \| Respond to of 544

CYPB Is doing well today (up 14.29%<g>)albeit on low volume.<g> (only 2000 shares) It had reported better revenues and earnings for the three months ended March 31, (revenues rose from $400 thousand to $6.4 million and net income to $4.1 M vs. a loss of $1.2 million.)(That was $0.59/share for the Q.)Will have to wait and see if that trend continues.<g> They said the increase in revenues reflected a deferred income from Fresenius agreement and the improved net reflected higher margins and lower interest expenses. At any rate it seems it should test the resistance at the 2.12 level.<g> siliconinvestor.com Bernard